Notably, B7 inhibits tumor progression, specifically bolstered natural killer (NK) cell‐mediated cytotoxicity, and mitigates the immunosuppressive microenvironment in intracranial xenograft mice implanted with GBM cells and GSCs, as well as in cocultures of GSCs and NK‐92 cells. The gene discussed is CD80; the disease is glioblastoma.